Layered double hydroxide: Inorganic organic conjugate nanocarrier for methotrexate

Layered double hydroxide (LDH)–methotrexate (MTX) nanohybrids were successfully synthesized using ex situ and in situ processes. X-ray diffraction patterns of the synthesized nanopowders revealed that intercalated MTX molecules were stabilized in tilted longitudinal conformation into the hydroxide i...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of physics and chemistry of solids 2011-06, Vol.72 (6), p.779-783
Main Authors: Chakraborty, Manjusha, Dasgupta, Sudip, Bose, Poulomi, Misra, Akhilesh, Kumar Mandal, Tapan, Mitra, Manoj, Chakraborty, Jui, Basu, Debabrata
Format: Article
Language:English
Subjects:
A. Ceramics
A. Inorganic compounds
A. Nanostructures
B. Chemical synthesis
C. Electron microscopy
Formulations
Hydroxides
Methotrexate
Nanocomposites
Nanomaterials
Nanostructure
Synthesis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Layered double hydroxide (LDH)–methotrexate (MTX) nanohybrids were successfully synthesized using ex situ and in situ processes. X-ray diffraction patterns of the synthesized nanopowders revealed that intercalated MTX molecules were stabilized in tilted longitudinal conformation into the hydroxide interlayer space. Two separate hydroxyl peaks were found in the FTIR spectra of LDH–MTX nanopowders suggesting successful intercalation of the MTX molecule into LDH matrix. The synthesized powders were further characterized using transmission electron microscopy (TEM) and selected area electron diffraction (SAED) pattern. HRTEM images showed an increase in interlayer spacing in hydrothermally crystallized LDH–MTX nanohybrids as compared to pristine LDH. The study showed that depending on the synthesis route used to synthesize LDH–MTX nanohybrid, its particle size as well as morphology can be varied at nano scale. ►Mg Al layered double hydroxide methotrexate forms the drug delivery formulation ► The particle size of the formulation is variable depending on the synthesis route ►Methotrexate loading in the formulation vary depending on the synthesis routes ► The formulations show controlled release up to a period of 170 h (>7 days).
ISSN:0022-3697
1879-2553
DOI:10.1016/j.jpcs.2011.03.012